 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease |
| Jang Wook Lee, Chang Hwan Choi, Ji Hoon Park, Jeong Wook Kim, Sang Bum Kang, Ja Seol Koo, Young-Ho Kim, You Sun Kim, Young Eun Joo, Sae Kyung Chang |
|
Intest Res. 2016;14(2):146-151. Published online April 27, 2016 DOI: https://doi.org/10.5217/ir.2016.14.2.146 |
|
Sa1119 Clinical Features of Active Tuberculosis Developed During Anti-Tumor Necrosis Factor-α Therapy in Patients With Inflammatory Bowel Diseases Gastroenterology. 2015;148(4):S-231  Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease Intestinal Research. 2016;14(2):146 Preliminaries Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ; Neutralisation of Soluble Tumor Necrosis Factor Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;83-89 Anti-TNF-α Therapy for Extraintestinal Manifestations of Inflammatory Bowel Disease Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;206-213 Author Index Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;234-234 Subject Index Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. ;235-240 INCIDENCE OF ACTIVE TUBERCULOSIS WITHIN 1 YEAR AFTER TUMOR NECROSIS FACTOR INHIBITOR TREATMENT ACCORDING TO LTBI STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Respirology. 2018;23:319-319 Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Gastroenterology. 2017;153(4):1163-1164 Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease Alimentary Pharmacology & Therapeutics. 2007;27(1):19-30 |
